Mining protein lists from proteomics studies: applications for drug discovery

Importance of the field: In recent years, proteomics has become a common technique applied to a wide spectrum of scientific problems, including the identification of diagnostic biomarkers, monitoring the effects of drug treatments or identification of chemical properties of a protein or a drug. Although being significantly different in scientific essence, the ultimate result of the majority of proteomics studies is a protein list. Thousands of independent proteomics studies have reported protein lists in various functional contexts. Areas covered in this review: We review here the spectrum of scientific problems where proteomics technology was applied recently to deliver protein lists. The available bioinformatics methods commonly used to understand the properties of the protein lists are compared. What the reader will gain: The types and common functional properties of the reported protein lists are discussed. The range of scientific problems where this knowledge could be potentially helpful with a focus on drug discovery issues is explored. Take home message: Reported protein lists represent a valuable resource which can be used for a variety of goals, ranging from biomarkers discovery to identification of novel therapeutic implications of known drugs.

[1]  Michael Neumaier,et al.  Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective , 2009, Clinical chemistry and laboratory medicine.

[2]  S. Hirohashi,et al.  Pfetin as a prognostic biomarker in gastrointestinal stromal tumor: novel monoclonal antibody and external validation study in multiple clinical facilities. , 2010, Japanese journal of clinical oncology.

[3]  Ramars Amanchy,et al.  Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC). , 2005, Journal of proteome research.

[4]  C. Fenselau,et al.  Solution isoelectric focusing for peptide analysis: comparative investigation of an insoluble nuclear protein fraction. , 2005, Journal of proteome research.

[5]  Dominik Lutter,et al.  GeneSet2miRNA: finding the signature of cooperative miRNA activities in the gene lists , 2009, Nucleic Acids Res..

[6]  Lennart Martens,et al.  PRIDE: a public repository of protein and peptide identifications for the proteomics community , 2005, Nucleic Acids Res..

[7]  Robertson Craig,et al.  Open source system for analyzing, validating, and storing protein identification data. , 2004, Journal of proteome research.

[8]  P. Geurts,et al.  Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study. , 2008, Clinical biochemistry.

[9]  M. Mann,et al.  Is Proteomics the New Genomics? , 2007, Cell.

[10]  Lennart Martens,et al.  Functional annotation of proteins identified in human brain during the HUPO Brain Proteome Project pilot study , 2006, Proteomics.

[11]  M. Merville,et al.  New biomarkers of Crohn’s disease: serum biomarkers and development of diagnostic tools , 2008, Expert review of molecular diagnostics.

[12]  B. Oliva,et al.  Biological pathways contributing to organ-specific phenotype of brain metastatic cells. , 2008, Journal of proteome research.

[13]  Nathan Edwards,et al.  Integration of 18O labeling and solution isoelectric focusing in a shotgun analysis of mitochondrial proteins. , 2007, Journal of proteome research.

[14]  Florian P Breitwieser,et al.  Acid elution and one-dimensional shotgun analysis on an Orbitrap mass spectrometer: an application to drug affinity chromatography. , 2009, Journal of proteome research.

[15]  Troels Z. Kristiansen,et al.  Comprehensive proteomic analysis of human pancreatic juice. , 2004, Journal of proteome research.

[16]  H. Kawasaki,et al.  Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma , 2006, Proteomics.

[17]  Steven A Carr,et al.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.

[18]  Tabiwang N. Arrey,et al.  Membrane protein analysis using an improved peptic in‐solution digestion protocol , 2009, Proteomics.

[19]  Nan Zhang,et al.  Lipid raft proteomics: Analysis of in‐solution digest of sodium dodecyl sulfate‐solubilized lipid raft proteins by liquid chromatography‐matrix‐assisted laser desorption/ionization tandem mass spectrometry , 2004, Proteomics.

[20]  A. Gotoh,et al.  Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma , 2008, Proteomics.

[21]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[22]  H. Mewes,et al.  PPI spider: A tool for the interpretation of proteomics data in the context of protein–protein interaction networks , 2009, Proteomics.

[23]  Purvesh Khatri,et al.  Recent additions and improvements to the Onto-Tools , 2005, Nucleic Acids Res..

[24]  Y. She,et al.  Using immobilized metal affinity chromatography, two-dimensional electrophoresis and mass spectrometry to identify hepatocellular proteins with copper-binding ability. , 2004, Journal of proteome research.

[25]  S. Gygi,et al.  Identification of protein components in in vivo human acquired enamel pellicle using LC-ESI-MS/MS. , 2007, Journal of proteome research.

[26]  G. Sauter,et al.  Loss of Expression of the Adipocyte-type Fatty Acid-binding Protein (A-FABP) Is Associated with Progression of Human Urothelial Carcinomas* , 2005, Molecular & Cellular Proteomics.

[27]  Gerhard Dürnberger,et al.  Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets. , 2007, Blood.

[28]  D. Wishart,et al.  Liquid chromatography electrospray ionization and matrix-assisted laser desorption ionization tandem mass spectrometry for the analysis of lipid raft proteome of monocytes. , 2008, Analytica chimica acta.

[29]  Lennart Martens,et al.  PRIDE: new developments and new datasets , 2007, Nucleic Acids Res..

[30]  J. Piette,et al.  Differential expression of proteins in response to ceramide-mediated stress signal in colon cancer cells by 2-D gel electrophoresis and MALDI-TOF-MS. , 2005, Journal of proteome research.

[31]  Hoguen Kim,et al.  Proteomic analysis distinguishes basaloid carcinoma as a distinct subtype of nonsmall cell lung carcinoma , 2004, Proteomics.

[32]  Ronald Simon,et al.  Bladder Cancer-associated Protein, a Potential Prognostic Biomarker in Human Bladder Cancer* , 2009, Molecular & Cellular Proteomics.

[33]  Oliver Fiehn,et al.  Pathway analysis of kidney cancer using proteomics and metabolic profiling , 2006, Molecular Cancer.

[34]  Hsuan-Cheng Huang,et al.  Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells. , 2006, Journal of proteome research.

[35]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[36]  J. Bunkenborg,et al.  Up‐regulated Proteins in the Fluid Bathing the Tumour Cell Microenvironment as Potential Serological Markers for Early Detection of Cancer of the Breast , 2010, Molecular oncology.

[37]  Philip Wong,et al.  PLIPS, an automatically collected database of protein lists reported by proteomics studies. , 2009, Journal of proteome research.

[38]  Thorsten Schmidt,et al.  ProfCom: a web tool for profiling the complex functionality of gene groups identified from high-throughput data , 2008, Nucleic Acids Res..

[39]  Purvesh Khatri,et al.  Ontological analysis of gene expression data: current tools, limitations, and open problems , 2005, Bioinform..

[40]  M. Neumaier,et al.  Mass spectrometry-based clinical proteomics profiling: current status and future directions , 2009, Expert review of proteomics.

[41]  Daniel W Chan,et al.  The clinical application of proteomics. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[42]  G. Cagney,et al.  Activity profiling of platelets by chemical proteomics , 2009, Proteomics.

[43]  H. Mewes,et al.  KEGG spider: interpretation of genomics data in the context of the global gene metabolic network , 2008, Genome Biology.

[44]  Rafael C. Jimenez,et al.  The IntAct molecular interaction database in 2012 , 2011, Nucleic Acids Res..

[45]  S. Ménard,et al.  Protein profile changes in the human breast cancer cell line MCF‐7 in response to SEL1L gene induction , 2005, Proteomics.

[46]  D. Jacobowitz,et al.  High abundance protein profiling of cystic fibrosis lung epithelial cells , 2005, Proteomics.

[47]  Kiyoko F. Aoki-Kinoshita,et al.  From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..

[48]  M. Glocker,et al.  Proteomic analysis of the E2F1 response in p53‐negative cancer cells: New aspects in the regulation of cell survival and death , 2006, Proteomics.

[49]  G. Koh,et al.  Membrane proteomic analysis of human mesenchymal stromal cells during adipogenesis , 2007, Proteomics.

[50]  G. Superti-Furga,et al.  A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells , 2010, Leukemia.

[51]  T. Luider,et al.  Proteomic analysis of nasal cells from cystic fibrosis patients and non‐cystic fibrosis control individuals: Search for novel biomarkers of cystic fibrosis lung disease , 2006, Proteomics.

[52]  B. Seliger,et al.  Candidate biomarkers in renal cell carcinoma , 2007, Proteomics.

[53]  A. Pandey,et al.  Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) for Studying Dynamics of Protein Abundance and Posttranslational Modifications , 2005, Science's STKE.

[54]  Guoqiang Chen,et al.  Subcellular proteome analysis of camptothecin analogue NSC606985-treated acute myeloid leukemic cells. , 2007, Journal of Proteome Research.

[55]  A. Bauch,et al.  An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells , 2006, Nature Methods.

[56]  F. Miller,et al.  Proteomic analysis of estrogen response of premalignant human breast cells using a 2‐D liquid separation/mass mapping technique , 2006, Proteomics.

[57]  John Sharkey,et al.  Apoptosis induced by staurosporine alters chaperone and endoplasmic reticulum proteins: Identification by quantitative proteomics , 2007, Proteomics.

[58]  B. Oliva,et al.  Functional clustering of metastasis proteins describes plastic adaptation resources of breast-cancer cells to new microenvironments. , 2008, Journal of proteome research.

[59]  Valerie Cavett,et al.  Strategies to recover proteins from ocular tissues for proteomics , 2007, Proteomics.

[60]  Eric W. Deutsch,et al.  The PeptideAtlas project , 2005, Nucleic Acids Res..

[61]  M. Sokolov,et al.  Analysis of protein expression and compartmentalization in retinal neurons using serial tangential sectioning of the retina. , 2009, Journal of proteome research.

[62]  Fuchu He,et al.  The Human Liver Proteome Project (HLPP) Workshop during the 4th HUPO World Congress , 2006, Proteomics.

[63]  L. Lefièvre,et al.  Human spermatozoa contain multiple targets for protein S‐nitrosylation: An alternative mechanism of the modulation of sperm function by nitric oxide? , 2007, Proteomics.